Association of aspirin with all-cause and cardiocerebrovascular mortality in patients with metabolic associated fatty liver disease.
Sign Up to like & getrecommendations! Published in 2023 at "Scandinavian journal of gastroenterology"
DOI: 10.1080/00365521.2023.2179864
Abstract: BACKGROUND Studies on aspirin's effects on metabolic-associated fatty liver disease (MAFLD) are limited. The aim of this study was to assess the association between aspirin and all-cause and cardiovascular disease (CVD) mortality in individuals with… read more here.
Keywords: aspirin cause; mortality; association aspirin; aspirin ... See more keywords